Immunome, Inc.
IMNM
$20.98
$0.271.28%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 12.90% | -21.99% | -20.14% | 67.84% | 13.37% |
| Total Depreciation and Amortization | 30.42% | 28.37% | 6.98% | 176.05% | 131.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -44.44% | -41.92% | -45.22% | -95.70% | -61.00% |
| Change in Net Operating Assets | -39.05% | 361.91% | -510.37% | -479.71% | 166.74% |
| Cash from Operations | -14.01% | -18.56% | -111.14% | -374.98% | -140.91% |
| Capital Expenditure | -255.15% | 27.49% | 61.39% | -69.36% | -222.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 387.58% | 20.26% | 124.96% | 127.96% |
| Cash from Investing | -140.98% | 414.08% | 21.44% | 113.67% | 132.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,148.36% | 8,997.84% | -81.51% | -26.06% | 5,421.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6,845.50% | -350.49% | 42.43% | 25.93% | -100.73% |
| Cash from Financing | 2,054.82% | 14,781.64% | -107.93% | -26.07% | -63.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,217.32% | 1,418.75% | -8.85% | -33.20% | -251.99% |